Why the study?
Do variants in ACE and TP53 contribute to the heritability of albuminuria and hypertension in an Aboriginal Australian community?
Cross-Sectional (n=357)
No
Do variants in ACE and TP53 contribute to the heritability of albuminuria and hypertension in an Aboriginal Australian community?
Significant genetic contributions, specifically from ACE and TP53 variants, explain a portion of the high heritability of albuminuria and hypertension in this Aboriginal Australian community.
BACKGROUND: Aboriginal Australians are at high risk of cardiovascular, metabolic and renal diseases, resulting in a marked reduction in life expectancy when compared to the rest of the Australian population. This is partly due to recognized environmental and lifestyle risk factors, but a contribution of genetic susceptibility is also likely. METHODS: Using results from a comprehensive survey of one community (N = 1350 examined individuals), we have tested for familial aggregation of plasma glucose, arterial blood pressure, albuminuria (measured as urinary albumin to creatinine ratio, UACR) and estimated glomerular filtration rate (eGFR), and quantified the contribution of variation at four candidate genes (ACE; TP53; ENOS3; MTHFR). RESULTS: = 11%) were significantly heritable. The ACE insertion-deletion (P = 0.0009) and TP53 codon72 polymorphisms (P = 0.003) together contributed approximately 15% of the total heritability of UACR, with an effect of ACE genotype on BP also clearly evident. CONCLUSIONS: While the effects of the ACE insertion-deletion on risk of renal disease (especially in the setting of diabetes) are well recognized, this is only the second study to implicate p53 genotype as a risk factor for albuminuria - the other being an earlier study we performed in a different Aboriginal community (McDonald et al., J Am Soc Nephrol 13: 677-83, 2002). We conclude that there are significant genetic contributions to the high prevalence of chronic diseases observed in this population.
No takes yet. Share an insight, caveat, or question.
Duffy et al. (2016) conducted a cross-sectional in Albuminuria and arterial hypertension (n=357). ACE insertion-deletion polymorphism (D/I vs I/I) vs. ACE I/I genotype was evaluated on Macroalbuminuria (>33 g/mol) (RR 2.2, p=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: